Abstract: Tumor volume has been considered an important variable in determining the probability of prostate-specific antigen (PSA) recurrence in prostatic adenocarcinoma. There have been many studies that have tried to determine an appropriate method of calculating tumor volume, but no single methodology has been agreed upon. We tested the hypothesis that the ratio of tumor positive tissue blocks to the total number of blocks submitted (positive-block ratio) can be used as an independent prognostic indicator for PSA recurrence. We analyzed 504 patients who underwent total radical retropubic prostatectomy between 1990 and 1998. None of the patients had preoperative radiation or androgen-deprivation therapy. Clinical records were reviewed. The mean positive-block ratio was 0.44 (median, 0.43; range, 0.05 to 1.0). The positive block-ratio was significantly associated with Gleason score, pathologic stage, surgical margin status, extraprostatic extension, seminal vesical invasion, lymph node metastasis, perineural invasion, and preoperative serum PSA level (all P<0.001). Using a multivariate Cox regression model, controlling for pathologic stage, Gleason score, lymph node metastasis, and surgical margin status, positive-block ratio was an independent predictor of PSA recurrence (hazard ratio, 2.3; 95% confidence interval, 1.06-4.83; P = 0.03). Five-year PSA recurrence-free survival was 67% for those patients with positive-block ratio r0.43, as compared with 42% those with positive-block ratio >0.43 (P<0.001). Positive-block ratio is an independent predictor of PSA recurrence and this simple method of tumor measurement seems to be promising for quantifying tumor volume if our findings are validated by subsequent reports.
M
any predictors of prostate-specific antigen (PSA) recurrence for prostatic adenocarcinoma have been established over the years including preoperative PSA, Gleason score, tumor stage, and surgical margin status. 6, 12, 13, 14, 15, 31, 36, 42 Tumor volume, however, has not consistently been shown to be an independent predictor of PSA recurrence. 5, 7, 10, 13, 16, 20, 21, 32, 34, 41, 43 This is likely largely in part to the problematic process of determining tumor volume. Prostatic carcinoma are often multifocal and difficult to identify grossly. 2, 11, 23 Multiple methodologies of evaluating tumor volume used in previous studies include measuring the maximum tumor diameter, 7, 19, 20, [38] [39] [40] maximum tumor area, 38 grid morphometric analysis, 27 3-dimensional estimates, 9, 17 visual estimation of tumor extent, 7, 8, 28, 30, 33, 37 and computer-assisted image analysis. 3, 7, 21, 35, 39 No single methodology of tumor volume determination has consistently been found to be reliable, reproducible, and economical. In the current study, we determined whether the ratio of tumor positive blocks to the number of blocks submitted for histologic examination (positive-block ratio) correlates with other known prognostic factors and whether the positive-block ratio is an independent variable associated with PSA recurrence in prostate cancer patients.
MATERIALS AND METHODS
Between 1990 and 1998, 504 men with clinically localized prostate cancer underwent retropubic radical prostatectomy at Indiana University Hospital. None of the patients had preoperative radiation or androgendeprivation therapy. Clinical records were reviewed to determine patient age, preoperative serum PSA levels, and evidence of biochemical recurrence (increasing serum PSA after surgery). 14, 25 Patients were followed at 6-month intervals for 2 years and annually thereafter. PSA recurrence was defined by consecutively elevated postoperative serum PSA levels (at least 0.1 ng/mL after surgery).
formalin. After fixation, the apex and bladder base were amputated and serially sectioned at 3 to 5 mm intervals in the vertical, parasagittal plane. The seminal vesicles were amputated and sectioned with representative sections examined. Sections including the junction between the seminal vesicle and the prostate proper were included. The remaining prostate was serially sectioned at 4 mm intervals perpendicular to the long axis (rectal surface), from the apex of the prostate to the bladder base. Partial sampling method was used. When no grossly visible tumor was identified, alternative transverse slice was submitted in 4 blocks (per slice), representing each quadrant. In a large prostate with benign prostatic hyperplasia, the peripheral zone of the prostate was preferentially sampled. When a grossly visible tumor was present, the entire tumor including adjacent periprostatic tissue was sampled.
Histologic sections were then prepared and stained with hematoxylin and eosin. Tumors were graded according to the Gleason grading system and staged according the 1997 American Joint Committee on Cancer (AJCC) TNM staging system. 22 In 1992, the AJCC and the International Union Against Cancer (UICC) adopted a unified TNM staging system for prostate carcinoma. T2 disease was defined as palpable prostate-confined tumor and was subdivided into 3 categories: T2a (unilateral tumor involving one-half of a lobe or less), T2b (unilateral tumor involving greater than one-half a lobe), and T2c (bilateral disease). 4 In 1997, the TNM staging system was revised by the AJCC to reduce the number of T2 subdivisions. Unilateral disease was combined into a single subdivision, T2a, and bilateral tumor involvement was reclassified as T2b. The sixth edition of the AJCC staging system, adopted in 2002, reincorporated the 3 clinical subdivisions for T2 tumors. 24 Controversy exists regarding the appropriate subclassification of pT2 and pT3 prostate carcinoma. 1, 26, 44, 45 Tumors in this study were graded according to the Gleason grading system and staged according to the 1997 AJCC TNM staging system. 22 The 1997 TNM staging system was used because a recent study indicated that pT2b tumors as defined by 2002 TNM probably do not exist. 18 Each slide was evaluated for the presence of tumor foci. The blocks containing the apical margin, bladder base margin, seminal vesicles, and lymph nodes were excluded from the number of blocks with tumor involvement and the total number of blocks. The remaining blocks of the gland were then analyzed to determine whether prostatic adenocarcinoma was present. The ratio was then determined as the number of those blocks positive for tumor over the total number of blocks.
Data analyses were performed by using SAS program (version 9.1.2, SAS Institute, Cary, NC). The time from surgery to PSA recurrence or the date of last follow-up was recorded, and PSA recurrence-free survival estimates were estimated by the Kaplan-Meier method. For patient characteristics, t tests and w 2 tests were used respectively for continuous and categorical variables in the tables. Positive-block ratio was analyzed as a continuous variable.
For illustrative purpose, Kaplan-Meier curves were generated for those patients with ratio of tumor positive blocks to total blocks below the median and above the median. The effect of positive-block ratio, and the associations between PSA recurrence-free survival and other clinical and pathologic measures, was assessed in a Cox regression model using SAS Proc Phreg. The effect of positive-block ratio was assessed controlling for Gleason score, pathologic stage (stratified at 3 levels, pT2, pT3a, and pT3b), surgical margin status, and lymph node status. An ordinal variable of 3 levels for pathologic stage was created; the variable takes value of 0 for stage 2 or less, 1 is for stage 3a, and 2 for stage 3b. All P values were 2-sided and results were considered significant if the P value was less than 0.05.
RESULTS
This cohort consisted of 504 patients who underwent prostatectomy for localized prostate cancer. The mean age of the patients was 62 years (median, 63; range, 34 to 80). The other clinical and pathologic variables are listed in Table 1 .
The total number of blocks examined ranged from 12 to 44 (mean, 12; median, 12). The number of positive blocks ranged from 1 to 18 (mean, 5; median, 5). The positive-block ratio ranged from 0.05 to 1.00 (mean, 0.44; median, 0.43). Univariate analysis showed a statistically significant association between positive block-ratio and preoperative serum PSA level, tumor stage, Gleason score, surgical margins, extraprostatic extension, seminal vesicle invasion, lymph node metastasis, and perineural invasion (all P<0.001; Table 1 ). Positive-block ratio was not associated with patient's age, prostate weight, or high-grade prostatic intraepithelial neoplasia.
In a Cox univariate analysis, preoperative serum PSA level (P<0.001), tumor stage (P<0.001), Gleason score (P<0.001), surgical margins (P<0.001), extraprostatic extension(P<0.001), seminal vesicle invasion (P<0.001), perineural invasion (P<0.0001), lymph node metastasis (P<0.001) were associated with PSA recurrence; whereas age at surgery (P = 0.12), prostate weight (P = 0.67), and high-grade prostatic intraepithelial neoplasia (P = 0.09) were not associated with PSA recurrence.
In a Cox regression model controlling for pathologic stage, Gleason score, and surgical margin status, and lymph node metastasis, the positive-block ratio was an independent predictor of PSA recurrence (hazard ratio, 2.3; 95% confidence interval, 1.06-4.83; P = 0.03; Table 2 ). Two-year, 5-year, and 10-year PSA recurrencefree survival was 80%, 67%, 50%, respectively, for those patients with positive-block ratio r0.43, as compared with 59%, 42%, and 33%, for those with positive-block ratio >0.43 (P<0.001) (Fig. 1) .
DISCUSSION
Our study of 504 patients indicates that positiveblock ratio is an independent predictor of PSA recurrence. Positive-block ratio may serve as a surrogate marker of tumor volume, and this technique of volume calculation could be easily applied to any practice setting because it does not require that the entire specimen be embedded; rather it takes into account only the ratio of positive blocks present in the sampled tissues of the prostate gland. The block ratio method also negates the need to use mapping or computer-assisted volumetric determinations, 7, 28 further easing its applicability to most pathology practices.
The present findings provide a much simpler methodology in evaluating tumor extent than those suggested in the past to measure tumor volume. Methodologies including the maximum tumor diameter, computer-assisted volumetric determinations, maximum tumor area, grid morphometric analysis, 3-dimensional estimates, and visual estimation of tumor extent have been suggested in the past, but no one modality has been agreed upon. Additionally, many of these practices cannot be realistically applied to most pathology practice settings. Our findings suggest that the ratio of blocks which contain tumor can be a reliable predictor of PSA recurrence, applicable to all pathology practice settings regardless of partial or complete sampling methodology used.
Our methodology of evaluating tumor extent is similar to those described by Jones. 29 In a study of 52 radical prostatectomy specimens, the author counted the number of blocks containing tumor and the number of slides that had greater than 50% involvement by tumor. He showed a significant correlation between the number of tumor positive blocks and resection margin status. Additionally, he showed that tumor extent significantly correlated with Gleason score, seminal vesicle status, and capsule status. We used a much larger population (504 *In the multivariate analysis, the pathologic stage was analyzed at 3 levels, stratified by organ-confined cancer (pT2); extraprostatic extension without seminal vesicle invasion (pT3a); and seminal vesical invasion (pT3b).
CI indicates confidence interval. FIGURE 1. Positive-block ratio was analyzed as continuous variable. For illustrative purpose, Kaplan-Meier curves were generated for those patients with ratio of tumor positive blocks to total blocks below the median and above the median (0.43). radical prostatectomy specimens), with longer follow-up data, to determine the relationship of these variables to documented PSA recurrence. Our studies showed the significance of positive-block ratio in predicting PSA recurrence in both univariate and multivariate analyses. The technique of determining the positive-block ratio has several limitations. Interobserver variability is a potential problem in that perhaps a small focus could be overlooked and alter the positive-block ratio. All histologic slides were evaluated by the same pathologist (L.C.) in our study; therefore, interobserver variability cannot be evaluated with the current study. Considering, however, that the evaluation is solely whether tumor is present or not and not predicting percentage involved or other subjective estimation, it is unlikely that interobserver variability would affect the ratios by a statistically significant margin. A study with multiple pathologists evaluating the ratio of positive blocks would be helpful to further evaluate interobserver variability. In our study, representative histologic sections per quadrant were reviewed; therefore, incomplete sampling could alter the results. It is unlikely that in most pathology practices the entire radical prostatectomy specimen would be submitted for pathologic evaluation, therefore making this study correlate more closely to the methodologies of most general pathology practices.
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One of the main limitations of this study is that the sampling variability has not been adequately addressed. Our method is highly dependent on how the prostate is submitted. In places where the prostates are totally submitted there is a greater likelihood that especially with large prostates with benign prostatic hyperplasia, there will be many transitional zone sections that do not contain tumor, which will decrease the positive-block ratio. This is in contrast to places where mostly the peripheral zone is submitted which will have a higher positive-block ratio. We should emphasize that the current study was a retrospective analysis and we realize that all the prostates may not have been sampled exactly the same. Furthermore, the P value for positive-block ratio, although statistically significant in the multivariate analysis (P = 0.03), may not hold up in future studies, especially given the potential for different results depending on how the prostates are sampled. The majority of prostate cancers are not grossly visible, only representative sections from each quadrant were examined in the current study. The number of blocks sampled from the prostate proper varied (from 12 to 44 blocks, excluding apical, bladder neck margins, seminal vesicles, and lymph nodes). However, we feel this could potentially be a strength of the current study, in that regardless of exactly how one chooses to sample the prostate, positive-ratio can be evaluated and used to describe tumor volume. A prospective study using variable methods of sampling would need to be performed to find out which would be the most appropriate to determine tumor volume, while also considering which would be most applicable to everyday pathology practice.
Tumor volume has been shown to be a potentially useful prognostic indicator of PSA recurrence, however, no single method for determining tumor volume has been agreed upon. The Association of Directors of Anatomic and Surgical Pathology recommends that some measurement of tumor volume be recorded even if it is a subjective quantification of ''minimal, moderate, and extensive.'' The College of American Pathologists recommends reporting the intraprostatic extent of cancer. 6 The ratio of positive blocks present of total blocks submitted as a methodology for determining tumor extent is both an independent determinant of biochemical disease recurrence and a technique that could be used with ease in all pathology practices if the findings in this study are supported by subsequent reports.
